422 related articles for article (PubMed ID: 21592994)
1. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.
Boulware DR; Hullsiek KH; Puronen CE; Rupert A; Baker JV; French MA; Bohjanen PR; Novak RM; Neaton JD; Sereti I;
J Infect Dis; 2011 Jun; 203(11):1637-46. PubMed ID: 21592994
[TBL] [Abstract][Full Text] [Related]
2. d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS.
Porter BO; Ouedraogo GL; Hodge JN; Smith MA; Pau A; Roby G; Kwan R; Bishop RJ; Rehm C; Mican J; Sereti I
Clin Immunol; 2010 Jul; 136(1):42-50. PubMed ID: 20227921
[TBL] [Abstract][Full Text] [Related]
3. D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events.
Freiberg MS; Bebu I; Tracy R; So-Armah K; Okulicz J; Ganesan A; Armstrong A; O'Bryan T; Rimland D; Justice AC; Agan BK;
PLoS One; 2016; 11(4):e0152588. PubMed ID: 27088215
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study.
Boulware DR; Meya DB; Bergemann TL; Wiesner DL; Rhein J; Musubire A; Lee SJ; Kambugu A; Janoff EN; Bohjanen PR
PLoS Med; 2010 Dec; 7(12):e1000384. PubMed ID: 21253011
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels.
Porter BO; Shen J; Kovacs JA; Davey RT; Rehm C; Lozier J; Csako G; Nghiem K; Costello R; Lane HC; Sereti I
AIDS; 2009 Sep; 23(15):2015-9. PubMed ID: 19617815
[TBL] [Abstract][Full Text] [Related]
6. Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.
Grund B; Baker JV; Deeks SG; Wolfson J; Wentworth D; Cozzi-Lepri A; Cohen CJ; Phillips A; Lundgren JD; Neaton JD;
PLoS One; 2016; 11(5):e0155100. PubMed ID: 27171281
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller LH; Tracy R; Belloso W; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Neuhaus J; Nixon D; Paton NI; Neaton JD;
PLoS Med; 2008 Oct; 5(10):e203. PubMed ID: 18942885
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with D-dimer levels in HIV-infected individuals.
Borges AH; O'Connor JL; Phillips AN; Baker JV; Vjecha MJ; Losso MH; Klinker H; Lopardo G; Williams I; Lundgren JD; ; ;
PLoS One; 2014; 9(3):e90978. PubMed ID: 24626096
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D, D-dimer, Interferon γ, and sCD14 Levels are Independently Associated with Immune Reconstitution Inflammatory Syndrome: A Prospective, International Study.
Musselwhite LW; Andrade BB; Ellenberg SS; Tierney A; Belaunzaran-Zamudio PF; Rupert A; Lederman MM; Sanne I; Sierra Madero JG; Sereti I
EBioMedicine; 2016 Feb; 4():115-23. PubMed ID: 26981576
[TBL] [Abstract][Full Text] [Related]
10. Pre-therapy inflammation and coagulation activation and long-term CD4 count responses to the initiation of antiretroviral therapy.
Achhra AC; Phillips A; Emery S; MacArthur RD; Furrer H; De Wit S; Losso M; Law MG;
HIV Med; 2015 Aug; 16(7):449-54. PubMed ID: 25959989
[TBL] [Abstract][Full Text] [Related]
11. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
[TBL] [Abstract][Full Text] [Related]
12. Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection.
Baker JV; Neuhaus J; Duprez D; Kuller LH; Tracy R; Belloso WH; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Nixon DE; Paton NI; Neaton JD;
J Acquir Immune Defic Syndr; 2011 Jan; 56(1):36-43. PubMed ID: 20930640
[TBL] [Abstract][Full Text] [Related]
13. Plasma But Not Cerebrospinal Fluid Interleukin 7 and Interleukin 5 Levels Pre-Antiretroviral Therapy Commencement Predict Cryptococcosis-Associated Immune Reconstitution Inflammatory Syndrome.
Akilimali NA; Chang CC; Muema DM; Reddy T; Moosa MS; Lewin SR; French MA; Ndung'u T
Clin Infect Dis; 2017 Oct; 65(9):1551-1559. PubMed ID: 29048509
[TBL] [Abstract][Full Text] [Related]
14. Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.
Sereti I; Krebs SJ; Phanuphak N; Fletcher JL; Slike B; Pinyakorn S; O'Connell RJ; Rupert A; Chomont N; Valcour V; Kim JH; Robb ML; Michael NL; Douek DC; Ananworanich J; Utay NS;
Clin Infect Dis; 2017 Jan; 64(2):124-131. PubMed ID: 27737952
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART Study.
; Peters L; Neuhaus J; Mocroft A; Soriano V; Rockstroh J; Dore G; Puoti M; Tedaldi E; Clotet B; Kupfer B; Lundgren JD; Klein MB
Antivir Ther; 2011; 16(5):667-75. PubMed ID: 21817188
[TBL] [Abstract][Full Text] [Related]
16. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment.
Tenorio AR; Zheng Y; Bosch RJ; Krishnan S; Rodriguez B; Hunt PW; Plants J; Seth A; Wilson CC; Deeks SG; Lederman MM; Landay AL
J Infect Dis; 2014 Oct; 210(8):1248-59. PubMed ID: 24795473
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results.
Kumar P; DeJesus E; Huhn G; Sloan L; Small CB; Edelstein H; Felizarta F; Hao R; Ross L; Stancil B; Pappa K; Ha B;
BMC Infect Dis; 2013 Jun; 13():269. PubMed ID: 23741991
[TBL] [Abstract][Full Text] [Related]
18. Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers.
Borges ÁH; Silverberg MJ; Wentworth D; Grulich AE; Fätkenheuer G; Mitsuyasu R; Tambussi G; Sabin CA; Neaton JD; Lundgren JD; ; ;
AIDS; 2013 Jun; 27(9):1433-41. PubMed ID: 23945504
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study.
Palella FJ; Gange SJ; Benning L; Jacobson L; Kaplan RC; Landay AL; Tracy RP; Elion R
AIDS; 2010 Jul; 24(11):1657-65. PubMed ID: 20588104
[TBL] [Abstract][Full Text] [Related]
20. Brief Report: Changes in Levels of Inflammation After Antiretroviral Treatment During Early HIV Infection in AIDS Clinical Trials Group Study A5217.
Macatangay BJ; Yang M; Sun X; Morton J; De Gruttola V; Little S; Hogan C; Rinaldo CR;
J Acquir Immune Defic Syndr; 2017 May; 75(1):137-141. PubMed ID: 28198712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
